A Randomized Phase III Trial of Melphalan and Dexamethasone (MDex) versus Bortezomib, Melphalan and Dexamethasone (BMDex) for Untreated Patients with AL Amyloidosis
A Randomized Phase III Trial of Melphalan and Dexamethasone (MDex) versus Bortezomib, Melphalan and Dexamethasone (BMDex) for Untreated Patients with AL Amyloidosis
复制标题
DOI：
10.1016/j.clml.2015.07.200
复制
发表时间：
2014-12
期刊：
影响因子：
--
通讯作者：
E. Kastritis;X. Leleu;B. Arnulf;E. Zamagni;M. Cibeira;F. Kwok;P. Mollee;R. Hájek;P. Moreau
中科院分区：
文献类型：
--
作者：
E. Kastritis;X. Leleu;B. Arnulf;E. Zamagni;M. Cibeira;F. Kwok;P. Mollee;R. Hájek;P. Moreau
